Immix Biopharma
IMMX
IMMX
18 hedge funds and large institutions have $1.01M invested in Immix Biopharma in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$154K | |
| 2 | +$76.9K | |
| 3 | +$58K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$36K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$28.8K |
Top Sellers
| 1 | -$37K | |
| 2 | -$16.8K | |
| 3 | -$530 | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5 |
| 5 |
Morgan Stanley
New York
|
-$4 |